Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.9K Hold
78
– – 0.01% 323
2026
Q2
$28.2K Sell
78
-58
-43% -$19.9K 0.01% 336
2026
Q1
$47.9K Hold
136
– – 0.02% 210
2025
Q4
$44.5K Buy
136
+58
+74% +$18.4K 0.02% 236
2025
Q3
$22K Hold
78
– – 0.01% 340
2025
Q2
$21.8K Hold
78
– – 0.01% 316
2025
Q1
$24.3K Sell
78
-5
-6% -$1.48K 0.02% 283
2024
Q4
$21.6K Sell
83
-49
-37% -$14.5K 0.01% 296
2024
Q3
$42.5K Hold
132
– – 0.03% 180
2024
Q2
$41.2K Sell
132
-7
-5% -$2.06K 0.03% 176
2024
Q1
$39.5K Sell
139
-39
-22% -$11.4K 0.03% 174
2023
Q4
$51.3K Hold
178
– – 0.04% 137

Other funds holding AMGN

WealthCollab's AMGN Position: Q3 2026 in Review

WealthCollab held its Amgen (AMGN) position steady in Q3 2026 at 78 shares worth $32.9K. The position accounts for 0.01% of the portfolio, ranked #323.

WealthCollab first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $51.3K in Q4 2023. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • WealthCollab held 78 shares of Amgen worth $32.9K as of Q3 2026.
  • WealthCollab left its Amgen share count unchanged in Q3 2026.
  • Amgen made up 0.01% of WealthCollab's portfolio in Q3 2026, its #323 holding.
  • WealthCollab first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
  • WealthCollab's Amgen position peaked at $51.3K in Q4 2023.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on WealthCollab's 13F filing for Q3 2026, filed 12 Nov 2026.